Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Anticancer Research|January 4, 2012
C15-functionalized 16-ene-1α,25-dihydroxyvitamin D3 is a new vitamin D analog with unique biological propertiesGo Kumagai, Masashi Takano, Kanako Shindo, et al.
Anticancer Research|July 25, 2008
Prostate 25-hydroxyvitamin D-1alpha-hydroxylase is up-regulated by suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitorLilin Wang, Kelly S Persons, Dan Jamieson, et al.
The American Journal of Clinical Nutrition|April 30, 2010
Fortification of orange juice with vitamin D(2) or vitamin D(3) is as effective as an oral supplement in maintaining vitamin D status in adultsRachael M Biancuzzo, Azzie Young, Douglass Bibuld, et al.
Drug Design, Development and Therapy|July 7, 2016
MART-10, a newly synthesized vitamin D analog, represses metastatic potential of head and neck squamous carcinoma cellsShih-Wei Yang, Chi-Ying Tsai, Yi-Chun Pan, et al.
Carcinogenesis|January 27, 2004
Pancreatic cancer cells express 25-hydroxyvitamin D-1 alpha-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxyvitamin D3Gary G Schwartz, Dawn Eads, Anuradha Rao, et al.
Anticancer Research|August 12, 2009
Evaluation of 19-nor-2alpha-(3-hydroxypropyl)-1alpha,25-dihydroxyvitamin D3 as a therapeutic agent for androgen-dependent prostate cancerJohn N Flanagan, Shasha Zheng, Kun-Chun Chiang, et al.
Stroke|August 10, 2013
Serum brain-derived neurotrophic factor and vascular endothelial growth factor levels are associated with risk of stroke and vascular brain injury: Framingham StudyAleksandra Pikula, Alexa S Beiser, Tai C Chen, et al.
JAMA Neurology|November 27, 2013
Serum brain-derived neurotrophic factor and the risk for dementia: the Framingham Heart StudyGalit Weinstein, Alexa S Beiser, Seung Hoan Choi, et al.
Anticancer Research|July 5, 2018
MART-10, a 1α,25(OH)2D3 Analog, Potently Represses Metastasis of ER+ Breast Cancer Cells with VEGF-A OverexpressionKun-Chun Chiang, Chun-Nan Yeh, Ta-Sen Yeh, et al.
American Journal of Physiology. Cell Physiology|December 17, 2010
20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cellsAndrzej T Slominski, Tae-Kang Kim, Zorica Janjetovic, et al.
Pageof 12